2015
DOI: 10.1002/mnfr.201500264
|View full text |Cite
|
Sign up to set email alerts
|

Urolithins, gut microbiota‐derived metabolites of ellagitannins, inhibit LPS‐induced inflammation in RAW 264.7 murine macrophages

Abstract: The anti-inflammatory effects of urolithins at concentrations that are physiologically relevant for gut tissues (≥40 μM), as revealed in this study, support the data from in vivo studies showing the beneficial effects of ellagitannin-rich products toward intestinal inflammation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

10
65
1
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 107 publications
(77 citation statements)
references
References 48 publications
10
65
1
1
Order By: Relevance
“…One unequivocal response we routinely observed upon UroA administration was the remarkable suppression of inflammation . In particular, we saw a significant reduction in the expression of proinflammatory markers, cytokines, and chemokines in liver, adipose, and macrophages of UroA‐injected mice (Figures , , and ).…”
Section: Discussionmentioning
confidence: 75%
“…One unequivocal response we routinely observed upon UroA administration was the remarkable suppression of inflammation . In particular, we saw a significant reduction in the expression of proinflammatory markers, cytokines, and chemokines in liver, adipose, and macrophages of UroA‐injected mice (Figures , , and ).…”
Section: Discussionmentioning
confidence: 75%
“…Additionally, a recent study further confirms the protective effect urolithins have over intestinal inflammation using RAW 264.7 murine macrophages as a model (Piwowarski et al, 2015). Urolithins A, B and C decreased NO production via inhibition of the iNOS protein, and expression of IL-1β, TNF-α and IL-6 (Piwowarski et al, 2015).…”
Section: Accepted Manuscriptmentioning
confidence: 74%
“…NO helps macrophages with immunological activity rebuff etiologic agents. 4) iNOS is an enzyme that produces NO when induced by lipopolysaccharide (LPS) or various pro-inflammatory cytokines and a high level of human iNOS is measured in macrophages from patients who have infections or inflammatory diseases.…”
Section: )mentioning
confidence: 99%
“…4) Inflammatory bowel diseases including ulcerative colitis (UC) and Crohn's disease (CD) are chronic relapsing disorders of the gastrointestinal tract characterized pathologically by epithelial injury and intestinal inflammation.…”
mentioning
confidence: 99%
See 1 more Smart Citation